SC Filed 2020-07-01 Event — SEC 0001193805-20-000766 →

Flynn James E → Larimar Therapeutics, Inc. LRMR

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

9 filings by this filer

8 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 3.89

7,639,333 shares short · +5.3% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $5.57M

Point72 Asset Mgmt

Other 13D/G Filings on Larimar Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2021-05-21	SC	Flynn James E	—	—	view →

Other Filings by Flynn James E

Filed	Form	Issuer	Stake	Shares
2025-03-03	SCHEDULE	BiomX Inc. PHGE	9.99%	15,558,445	view →
2025-02-25	SCHEDULE	Singular Genomics Systems, Inc.	100.00%	1,000	view →
2025-01-28	SCHEDULE	Acutus Medical, Inc.	9.10%	5,492,725	view →
2025-01-23	SCHEDULE	Acutus Medical, Inc.	9.10%	9,705,857	view →
2024-07-11	SC	BiomX Inc. PHGE	—	—	view →
2022-07-05	SC	Acutus Medical, Inc.	—	—	view →
2021-05-21	SC	Larimar Therapeutics, Inc. LRMR	—	—	view →
2018-04-04	SC	DFB Healthcare Acquisitions Corp. AHCO	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →